Cite

HARVARD Citation

    Gregory, G. et al. (n.d.). ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY. Hematological oncology. pp. 328-329. [Online]. 
  
Back to record